Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1994-09-20
1996-11-19
Prior, Kimberly J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
552610, 552648, A61K 3156
Patent
active
055763103
ABSTRACT:
This invention relates to new 11-benzaldoxime-estra-diene derivatives of the general formula I ##STR1## wherein Z is --CO--CH.sub.3, --CO--O--C.sub.2 H.sub.5, --CO--NH-phenyl, --CO--NH--C.sub.2 H.sub.5, --CO--C.sub.2 H.sub.5, --CH.sub.3, or --CO-phenyl
and their pharmaceutically acceptable salts, a method for their production, and pharmaceuticals containing such compounds. The compounds of the general formula I are produced by esterifying or etherizing a compound of the general formula II ##STR2## The compounds described show strong antigestagenic effects combined with reduced glucocorticoid activity.
REFERENCES:
patent: 4829060 (1989-05-01), Ottow et al.
patent: 4871724 (1989-10-01), Groen et al.
patent: 4912097 (1990-03-01), Teutsch et al.
patent: 5089635 (1992-02-01), Neef et al.
patent: 5272140 (1993-12-01), Loozen
patent: 5276023 (1994-01-01), Moguilewsky et al.
patent: 5407928 (1995-04-01), Kasch et al.
Elger Walter
Kaufmann G unther
Kurischko Anatoli
Oettel Michael
Schubert Gerd
Jenapharm GmbH
Prior Kimberly J.
LandOfFree
11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethyl-estrasd does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethyl-estrasd, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethyl-estrasd will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541127